Introduction: Autoimmune gastritis (AIG), a type of chronic atrophic gastritis, is characterized by positive anti-parietal cell antibodies and mucosal atrophy predominantly in the corpus. In Japan, AIG has garnered increasing attention owing to the recent decline in Helicobacter pylori (HP) infection rates, leading to the proposal of diagnostic criteria. These criteria encompass serological test results, endoscopic findings, and histological findings, emphasizing the need for collaboration between endoscopists and pathologists to make an accurate diagnosis. In the present study, we aimed to clarify the annual number of patients with AIG diagnosed over the past 11 years and analyze their endoscopic and histological characteristics. Methods: We retrospectively reviewed patients with AIG newly diagnosed at our institution between 2013 and 2023. Patients were categorized into the “prior endoscopically diagnosed group” (ED group) and the “prior pathologically diagnosed group” (PD group). The annual trend in AIG diagnosis was analyzed, and clinicopathological characteristics were compared between the groups. Results: In total, 118 patients were diagnosed with AIG during the study period. The number of diagnoses increased after 2018, when a focused effort to identify AIG began, peaking in 2021 with 32 cases. All patients diagnosed before 2018 belonged to the ED group, but subsequent years saw increases in both groups of patients. The PD group had significantly more cases of coexisting gastric carcinoma (86.3% vs. 26.9%, p < 0.001) or HP-associated gastritis (72.4% vs. 32.8%, p = 0.002) than the ED group, whereas the ED group frequently exhibited typical endoscopic findings, such as atrophic gastritis predominantly in the corpus and adherent mucus. Conclusion: Accurate diagnosis of AIG requires familiarity with the diagnostic criteria by endoscopists and pathologists. In cases complicated by gastric carcinoma or HP-associated gastritis, endoscopic findings alone may not suffice for diagnosis, underscoring the critical role of pathologists in interpreting histological findings.

1.
Greenson
JK
.
Diagnostic pathology: gastrointestinal
. 3rd edn.
Salt Lake City
:
Elsevier
;
2019
; p.
140
3
.
2.
Soykan
I
,
Yakut
M
,
Keskin
O
,
Bektaş
M
.
Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis
.
Digestion
.
2012
;
86
(
1
):
20
6
.
3.
Borch
K
,
Renvall
H
,
Kullman
E
,
Wilander
E
.
Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases
.
Am J Surg Pathol
.
1987
;
11
(
6
):
435
44
.
4.
Rappel
S
,
Altendorf-Hofmann
A
,
Stolte
M
.
Prognosis of gastric carcinoid tumours
.
Digestion
.
1995
;
56
(
6
):
455
62
.
5.
Namikawa
K
,
Kamada
T
,
Fujisaki
J
,
Sato
Y
,
Murao
T
,
Chiba
T
, et al
.
Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort
.
Dig Endosc
.
2023
;
35
(
6
):
757
66
.
6.
Elsborg
L
,
Mosbech
J
.
Pernicious anaemia as a risk factor in gastric cancer
.
Acta Med Scand
.
1979
;
206
(
4
):
315
8
.
7.
Vannella
L
,
Lahner
E
,
Osborn
J
,
Annibale
B
.
Systematic review: gastric cancer incidence in pernicious anaemia
.
Aliment Pharmacol Ther
.
2013
;
37
(
4
):
375
82
.
8.
Kitamura
S
,
Muguruma
N
,
Okamoto
K
,
Kagemoto
K
,
Kida
Y
,
Mitsui
Y
, et al
.
Clinicopathological characteristics of early gastric cancer associated with autoimmune gastritis
.
JGH Open
.
2021
;
5
(
10
):
1210
5
.
9.
Centanni
M
,
Marignani
M
,
Gargano
L
,
Corleto
VD
,
Casini
A
,
Delle Fave
G
, et al
.
Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association
.
Arch Intern Med
.
1999
;
159
(
15
):
1726
30
.
10.
Taniguchi
M
,
Sudo
G
,
Sekiguchi
Y
,
Nakase
H
.
Autoimmune gastritis concomitant with gastric adenoma and subacute combined degeneration of the spinal cord
.
BMJ Case Rep
.
2021
;
14
(
5
):
e242836
.
11.
Betterle
C
,
Zanchetta
R
.
Update on autoimmune polyendocrine syndromes (APS)
.
Acta Biomed
.
2003
;
74
(
1
):
9
33
.
12.
Shah
SC
,
Piazuelo
MB
,
Kuipers
EJ
,
Li
D
.
AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review
.
Gastroenterology
.
2021
;
161
(
4
):
1325
32.e7
.
13.
Strickland
RG
,
Mackay
IR
.
A reappraisal of the nature and significance of chronic atrophic gastritis
.
Am J Dig Dis
.
1973
;
18
(
5
):
426
40
.
14.
Coati
I
,
Fassan
M
,
Farinati
F
,
Graham
DY
,
Genta
RM
,
Rugge
M
.
Autoimmune gastritis: pathologist’s viewpoint
.
World J Gastroenterol
.
2015
;
21
(
42
):
12179
89
.
15.
Torbenson
M
,
Abraham
SC
,
Boitnott
J
,
Yardley
JH
,
Wu
TT
.
Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands
.
Mod Pathol
.
2002
;
15
(
2
):
102
9
.
16.
Kamada
T
,
Watanabe
H
,
Furuta
T
,
Terao
S
,
Maruyama
Y
,
Kawachi
H
, et al
.
Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan
.
J Gastroenterol
.
2023
;
58
(
3
):
185
95
.
17.
Kotera
T
,
Yoshioka
U
,
Takemoto
T
,
Kushima
R
,
Haruma
K
.
Evolving autoimmune gastritis initially hidden by active Helicobacter pylori gastritis
.
Case Rep Gastroenterol
.
2022
;
16
(
1
):
103
9
.
18.
Notsu
T
,
Adachi
K
,
Mishiro
T
,
Fujihara
H
,
Toda
T
,
Takaki
S
, et al
.
Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan
.
Intern Med
.
2019
;
58
(
13
):
1817
23
.
19.
Hirasawa
T
,
Higashi
Y
,
Nakano
K
,
Yamamoto
H
,
Fukuyama
C
,
Namikawa
K
, et al
.
Clinicopathological characteristics of gastric cancer associated with autoimmune gastritis
.
Stomach and Intestine
.
2024
;
59
(
1
):
63
75
.
20.
Uemura
N
,
Okamoto
S
,
Yamamoto
S
,
Matsumura
N
,
Yamaguchi
S
,
Yamakido
M
, et al
.
Helicobacter pylori infection and the development of gastric cancer
.
N Engl J Med
.
2001
;
345
(
11
):
784
9
.
21.
Dixon
MF
,
Genta
RM
,
Yardley
JH
,
Correa
P
.
Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994
.
Am J Surg Pathol
.
1996
;
20
(
10
):
1161
81
.
22.
Kato
M
,
Uedo
N
,
Toth
E
,
Shichijo
S
,
Maekawa
A
,
Kanesaka
T
, et al
.
Differences in image-enhanced endoscopic findings between Helicobacter pylori-associated and autoimmune gastritis
.
Endosc Int Open
.
2021
;
9
(
1
):
E22
-
30
.
23.
Nishizawa
T
,
Yoshida
S
,
Watanabe
H
,
Toyoshima
A
,
Kataoka
Y
,
Takahashi
Y
, et al
.
Clue of diagnosis for autoimmune gastritis
.
Digestion
.
2021
;
102
(
6
):
903
10
.
24.
Miceli
E
,
Lenti
MV
,
Padula
D
,
Luinetti
O
,
Vattiato
C
,
Monti
CM
, et al
.
Common features of patients with autoimmune atrophic gastritis
.
Clin Gastroenterol Hepatol
.
2012
;
10
(
7
):
812
4
.
25.
Park
JY
,
Cornish
TC
,
Lam-Himlin
D
,
Shi
C
,
Montgomery
E
.
Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting
.
Am J Surg Pathol
.
2010
;
34
(
11
):
1591
8
.
26.
Neumann
WL
,
Coss
E
,
Rugge
M
,
Genta
RM
.
Autoimmune atrophic gastritis—pathogenesis, pathology and management
.
Nat Rev Gastroenterol Hepatol
.
2013
;
10
(
9
):
529
41
.
27.
Okuno
H
,
Suzuki
S
,
Watanabe
H
,
Kusano
C
,
Ikehara
H
,
Moriyama
M
, et al
.
Histological features of gastric mucosa serologically diagnosed as gastric atrophy without Helicobacter pylori infection
.
Digestion
.
2020
;
101
(
2
):
217
26
.
28.
Choudhuri
J
,
Hall
S
,
Castrodad-Rodriguez
CA
,
Westerhoff
M
,
El Jabbour
T
,
Jain
S
, et al
.
Features that aid identification of autoimmune gastritis in a background of active Helicobacter pylori infection
.
Arch Pathol Lab Med
.
2021
;
145
(
12
):
1536
43
.
29.
Terao
S
,
Suzuki
S
,
Yaita
H
,
Kurahara
K
,
Shunto
J
,
Furuta
T
, et al
.
Multicenter study of autoimmune gastritis in Japan: Clinical and endoscopic characteristics
.
Dig Endosc
.
2020
;
32
(
3
):
364
72
.
You do not currently have access to this content.